Commission incorporates Parliament views in revised FP7 proposal

The European Commission has adopted an amended proposal for the Seventh Framework Programme (FP7), which seeks to incorporate amendments made by the European Parliament and the Council of Ministers in their first readings. The Commission reports that the revised proposals "take up in spirit and content if not necessarily always with the exact wording, to a large proportion the position taken by the other institutions".

The Commission adopted its original FP7 proposal in April 2005, while the budgetary aspects to the programme were adopted in May 2006, following agreement on the EU's Financial Perspectives for 2007 to 2013. The Parliament adopted the proposals by a broad majority in June 2006, proposing some 1700 amendments.

The themes set to receive funding under the Cooperation programme remain the same, with a number of clarifications, specifying areas in which research will be funded. These range from healthy ageing and infectious diseases to soil fertility, the sustainability of fisheries, platforms for software and services and nano-composites.

On Joint Technology Initiatives (JTIs), long-term public-private partnerships to boost technology in specific fields, the Commission accepts modifications on the criteria to be used for identifying potential JTIs, as well as their organisation and implementation.

For example, the new proposal adds that when assessing the need for a JTI: the existence of a genuine societal need and benefit; the scale of the impact on industrial competitiveness and growth; and the inability of existing instruments to achieve the objective should all be taken into account.

The amended proposal also emphasises that small and medium sized enterprises (SMEs), technology transfer and education should not be neglected by JTIs. The organisation of JTIs should ensure that "participation in their projects is open to a wide range of participants throughout Europe, and in particular SMEs".

The Commission also incorporates important clarifications on the European Research Council (ERC), and in particular on the term of office, the renewal and the role of the Scientific Council, the management and staffing arrangements, and the independent review of the ERC.

MEPs had requested a review of the ERC in 2008. Speaking to the Parliament during a debate on FP7, EU Science and Research Commissioner Janez Potocnik suggested that this would be too soon. The revised proposal states that the review will be carried out 'no later than 2010'.

The new document adds that the ERC shall have the ability to conduct its own strategic studies to prepare and support its operational activities.

Ethics were a major consideration for many parliamentarians, and the revised proposal seeks to allay concerns by specifying which areas will not receive any funding under FP7. These are human cloning for reproductive purposes, research intended to modify the genetic heritage of human beings which could make such changes heritable, and research intended to create human embryos solely for the purpose of research or the purpose of stem cell procurement.

To follow the debate on FP7, please visit:

http://cordis.europa.eu/fp7/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...